Abiopharma

Artelo Biosciences Announces Reverse Stock Split

TC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) Patient

Intensity Therapeutics, Inc. Announces Patients Receiving INT230-6 Prior to the Start of Standard-of-Care May Achieve High Levels of Tumor Necrosis in the Ongoing Randomized Controlled Phase 2 INVINCIBLE-4 Study

OKYO Pharma to Present at the Bio International Convention

Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing

Artelo Biosciences Announces Reverse Stock Split

Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada

Hoth Therapeutics Notification (HOTH)

SeaStar Medical - AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStarMedical’s SCD Therapy to Advance Breakthrough Burn and Sepsis Research

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical’s SCD Therapy to Advance Breakthrough Burn and Sepsis Research